Empresas y finanzas

Pall Opens New Centre of Excellence in India to Serve Fast-Growing Life Sciences Market



    As part of its global initiative to align with customers
    worldwide, Pall Corporation (NYSE: PLL) today inaugurated its newest
    Life Sciences Centre of Excellence in Bangalore, India. The Centre
    will drive process optimization innovations for the global life
    sciences market to meet the evolving opportunities and challenges of
    this fast-growing industry throughout Asia. The new Centre includes a
    state-of-the-art proteomics laboratory to help customers speed the
    drug discovery process. It also houses a validation laboratory and a
    training facility with specialty experts to support Indian and
    regional customers as they increasingly enter the stringently
    regulated drug export market.

    India was strategically chosen as the location for Pall's new
    Centre of Excellence in Asia because of the country's highly regarded
    reputation in life sciences spanning biopharmaceutical research,
    development and production. Additionally, India's diverse market
    opportunities coupled with a large pool of qualified scientists and
    engineers provide an ideal climate for fuelling innovation and growth.

    "Pall's growth in the Asian life sciences market is a reflection
    of our focus on this important region and our continuing commitment to
    undertake several customer-centric initiatives there," says Roberto
    Perez, president, Pall Life Sciences Worldwide. "The new Centre of
    Excellence will be instrumental in helping the life sciences industry
    in India and throughout the region apply the latest technologies and
    services to their operations, so they have the optimal tools and
    expertise to bring new and innovative drugs to market more
    efficiently."

    As Indian-based companies address the health care needs of their
    nation's billion plus population and also expand into the global
    marketplace, they constantly seek new approaches to broaden and
    improve their drug pipeline and their ability to produce them to a
    world-class standard. The new Centre will provide the pharmaceutical,
    biotechnology and discovery markets throughout the region with a full
    range of total fluid management solutions to help them achieve their
    goals. Led by a highly specialized team of professionals, the new
    Centre joins other Pall Life Sciences Centres of Excellence throughout
    Europe and the Western Hemisphere in bringing together the latest
    technologies with process optimization knowledge and expertise. With
    the opening of the Centre, Pall Life Sciences also expands its
    customer technical support system. Customers anywhere in the world
    will be able to have immediate access (24-hours, 7-days a week) to
    Pall scientists and technical experts.

    "The success of our customers depends on their ability to carry
    out all stages of drug development-- research, discovery and
    full-scale production -- efficiently and cost-effectively," says Vinay
    Joban, general manager, Pall BioPharmaceuticals India. "The new Centre
    provides the region with a complete range of services to support their
    operations from upstream through downstream while also facilitating
    their ability to comply with increasingly rigorous global
    requirements."

    The biopharmaceutical industry throughout Asia is experiencing a
    major surge in activity. The Indian pharmaceutical industry is one of
    the world's largest, ranking 4th in terms of volume. According to
    Opportunities in Indian Pharma Sector (July 2006), India holds US$ six
    billion of the $550 billion global pharmaceutical industry, an annual
    increase of 10 percent compared with the seven percent annual growth
    of the overall world market. The biotechnology market is also booming
    in India and is expected to continue on a fast pace with the support
    of the government through its comprehensive national biotechnology
    policy. Indian Biotechnology Market Outlook (February 2007) reports
    that the Indian biotechnology industry has grown 28.09 percent from
    2005, and is likely to touch the US$ five billion mark by the end of
    2010.

    "Our new Centre of Excellence is the latest demonstration of
    Pall's long-term commitment to grow and invest in Asia and align with
    our customer's worldwide," says Vinay Gupta, Managing Director and
    Head of Pall Life Sciences in India. "It is key to our global strategy
    of working as a partner with the pharmaceutical and biotechnology
    industries and the academic research community to provide them with a
    full range of total process management solutions for improved
    optimization."

    About Pall in India and Asia

    Pall Corporation has been present in India for more than two
    decades and was incorporated as Pall India in 1996. Headquartered in
    Mumbai, the Company serves both Life Sciences and Industrial markets
    where it provides total fluid management solutions for a broad range
    of critical applications to a diverse customer base. With staff
    strength of more than 200 people drawn from various disciplines and
    expertise, Pall continues to enhance and expand its operations in
    India. Currently, plans are underway to set up a new Centre in Pune to
    provide complete engineering solutions to the global market for Pall's
    housings and systems portfolio. In addition to its operations in
    India, Pall serves the Asia-Pacific region with facilities in China,
    Indonesia, Japan, Korea, Malaysia, Australia, New Zealand,
    Philippines, Singapore, Taiwan, Thailand and Vietnam.

    About Pall Corporation

    Pall Corporation is the global leader in the rapidly growing field
    of filtration, separation and purification. Pall is organized into two
    businesses: Life Sciences and Industrial. These businesses provide
    leading-edge products to meet the demanding needs of customers in
    biotechnology, pharmaceutical, transfusion medicine, energy,
    electronics, municipal and industrial water purification, aerospace,
    transportation and broad industrial markets. Total revenues for fiscal
    year 2006 were $2.0 billion. The company headquarters is in East
    Hills, New York, with extensive operations throughout the world. For
    more information visit Pall at www.pall.com.

    Editors' Notes:

    -- The Pall Life Sciences Centre of Excellence in Bangalore,
    India (20,000-sq.feet) is located at No.1, Sarakki
    Indl.Layout, J.P.Nagar 6th Phase, Opp.ICICI Bank, Bangalore -
    560 078, Phone 91-80-40164100

    -- Photos of the Centre, Pall executives and the lamp lighting
    ceremony to inaugurate the opening can be found on
    http://www.pall.com/corporate_43136.asp